Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer.
A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer. Ann Surg Oncol. 2014 Nov; 21(12):3931-7.
View in:
PubMed
subject areas
Adenocarcinoma
Adenocarcinoma
Adult
Adult
Aged
Aged
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Alkylating
Cancer Vaccines
Cancer Vaccines
Clinical Trials, Phase I as Topic
Clinical Trials, Phase I as Topic
Colorectal Neoplasms
Colorectal Neoplasms
Combined Modality Therapy
Combined Modality Therapy
Cyclophosphamide
Cyclophosphamide
Feasibility Studies
Feasibility Studies
Female
Female
Follow-Up Studies
Follow-Up Studies
Humans
Humans
Immunotherapy
Immunotherapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Lymphatic Metastasis
Lymphatic Metastasis
Macrophage Colony-Stimulating Factor
Macrophage Colony-Stimulating Factor
Male
Male
Middle Aged
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Neoplasm Staging
Neoplasm Staging
Prognosis
Prognosis
Safety
Safety
Survival Rate
Survival Rate
Tumor Cells, Cultured
Tumor Cells, Cultured
authors with profiles
Barish H Edil